News
New migraine drugs have promise — and a $8,500 price tag
A promising new group of drugs, named after calcitonin gene-related peptide (CGRP), a neurotransmitter tied to migraine, has changed that. CGRP drugs are being developed both to prevent migraines before they happen, and to stop attacks once they occur.
New Migraine Drugs On The Horizon
There are exciting advancements on the horizon in the area of treating and preventing migraine headaches. In the U.S. a host of new drugs are in the final stages of approval and testing.
Rebecca Erwin Wells: Member Spotlight
Dr. Wells believes in a team-based approach to care and empowering providers to fight headache stigma
Migraine Stigma May Prevent Proper Diagnosis and Treatment in Men
New study finds that the perception of migraine as a women’s disease may impact the diagnosis and treatment of migraine in men
Clinical Data Presented at American Headache Society Meeting Shows Promise of New Treatments for Migraine Prevention
Clinical data presented this week at the 58th Annual Scientific Meeting of the American Headache Society calls attention to the promise of new treatments in development for migraine prevention...
Migraine Patient Education about Medication Improves Self-Treatment
New Study Documents the Power of Migraine Medication Education in Helping Patients Manage Pain
Suboptimal Treatment of Episodic Migraine May Mean Progression to Chronic Migraine
Improved Acute Treatment of Episodic Migraine May Reduce Risk of Progression